Cat#:RP-212AC;Product Name:Recombinant Human SLAMF7 / CRACC / CD319 Protein;Synonym:SLAMF7,CD319,CS1,CRACC,19A,FOAP-12;Description:Human SLAMF7 with His Tag is produced in HEK293 cells. It contains AA Ser 23 - Met 226.;Source:HEK293;Predicted N Terminal:Ser 23;Molecular Characterization:Recombinant Human SLAMF7 / CRACC / CD319 Protein has a calculated MW of 23.2 kDa. The recombinant protein migrates as 33-48 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Purity:Greater than 95% as determined by SDS-PAGE.;Endotoxin:< 1.0 EU per μg of recombinant human SLAMF7 / CRACC / CD319 protein by the LAL method.;Formulation:Recombinant human SLAMF7 / CRACC / CD319 protein was lyophilized from 0.22 μm filtered solution in PBS, pH7.4.;Stability:Recombinant human SLAMF7 / CRACC / CD319 protein was stable up to 1 year from date of receipt at -70℃;Storage:Store recombinant human SLAMF7 / CRACC / CD319 protein under sterile conditions at -20℃ to -80℃. It is recommended that the recombinant protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.;Usage:For Lab Research Use Only;